Terns Pharmaceuticals Inc. buy BiotechBee
Start price
08.09.24
/
50%
€7.05
Target price
31.03.27
€20.00
Performance (%)
-5.67%
End price
14.12.24
€6.65
Summary
This prediction ended on 14.12.24 with a price of €6.65. With a performance of -5.67%, the BUY prediction for Terns Pharmaceuticals Inc. by BiotechBee closed slightly in the red. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Terns Pharmaceuticals Inc. | 58.400% | 58.400% | 528.571% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Terns Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Terns Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Terns Pharmaceuticals Inc.
Buy beendet
Stopped prediction by BiotechBee for Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€6.85
22.06.24
22.06.24
€10.00
30.04.26
30.04.26
2.92%
08.09.24
08.09.24
Could be very worthwhile Investment >20% year
Terns Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.87
24.06.23
24.06.23
€18.00
31.12.25
31.12.25
-45.26%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year

